| Genetic and functional drivers of diffuse large B cell lymphoma A Reddy, J Zhang, NS Davis, AB Moffitt, CL Love, A Waldrop, S Leppa, ... Cell 171 (2), 481-494. e15, 2017 | 992 | 2017 |
| PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase YL Kwong, TSY Chan, D Tan, SJ Kim, LM Poon, B Mow, PL Khong, ... Blood 129 (17), 2437-2442, 2017 | 491 | 2017 |
| SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group YL Kwong, WS Kim, ST Lim, SJ Kim, T Tang, E Tse, AYH Leung, CS Chim Blood 120 (15), 2973-2980, 2012 | 449 | 2012 |
| HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects MF Yuen, DKH Wong, E Sablon, E Tse, IOL Ng, HJ Yuan, CW Siu, ... Hepatology 39 (6), 1694-1701, 2004 | 372 | 2004 |
| Pembrolizumab (Keytruda) G Kwok, TCC Yau, JW Chiu, E Tse, YL Kwong Human vaccines & immunotherapeutics 12 (11), 2777-2789, 2016 | 340 | 2016 |
| How I treat NK/T-cell lymphomas E Tse, YL Kwong Blood, The Journal of the American Society of Hematology 121 (25), 4997-5005, 2013 | 338 | 2013 |
| Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme … WY Au, SY Ma, CS Chim, C Choy, F Loong, AKW Lie, CCK Lam, ... Annals of Oncology 16 (2), 206-214, 2005 | 306 | 2005 |
| The diagnosis and management of NK/T-cell lymphomas E Tse, YL Kwong Journal of hematology & oncology 10 (1), 1-13, 2017 | 295 | 2017 |
| Selection of antibodies for intracellular function using a two-hybrid in vivo system M Visintin, E Tse, H Axelson, TH Rabbitts, A Cattaneo Proceedings of the National Academy of Sciences 96 (21), 11723-11728, 1999 | 279 | 1999 |
| Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells J Leung, A Pang, WH Yuen, YL Kwong, EWC Tse Blood 109 (2), 740-746, 2007 | 173 | 2007 |
| Type II enteropathy‐associated T‐cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group E Tse, H Gill, F Loong, SJ Kim, SB Ng, T Tang, YH Ko, WJ Chng, ST Lim, ... American journal of hematology 87 (7), 663-668, 2012 | 170 | 2012 |
| Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international collaborative effort … MA Kharfan-Dabaja, A Kumar, E Ayala, M Hamadani, P Reimer, ... Biology of Blood and Marrow Transplantation 23 (11), 1826-1838, 2017 | 166 | 2017 |
| Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2 AB Moffitt, SL Ondrejka, M McKinney, RE Rempel, JR Goodlad, CH Teh, ... Journal of Experimental Medicine 214 (5), 1371-1386, 2017 | 162 | 2017 |
| Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis R Pang, TKW Lee, RTP Poon, ST Fan, KB Wong, YL Kwong, E Tse Gastroenterology 132 (3), 1088-1103, 2007 | 161 | 2007 |
| PIN1 overexpression and β-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma R Pang, J Yuen, MF Yuen, CL Lai, TKW Lee, K Man, RTP Poon, ST Fan, ... Oncogene 23 (23), 4182-4186, 2004 | 147 | 2004 |
| Quantification of circulating Epstein–Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance YL Kwong, AWK Pang, AYH Leung, CS Chim, E Tse Leukemia 28 (4), 865-870, 2014 | 129 | 2014 |
| Molecular pathways in hepatocellular carcinoma R Pang, E Tse, RTP Poon Cancer letters 240 (2), 157-169, 2006 | 123 | 2006 |
| Extranodal natural-killer/t-cell lymphoma, nasal type H Gill, RHS Liang, E Tse Advances in hematology 2010, 2010 | 115 | 2010 |
| Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma YW Chen, T Guo, L Shen, KY Wong, Q Tao, WWL Choi, RKH Au-Yeung, ... Blood, The Journal of the American Society of Hematology 125 (10), 1589-1600, 2015 | 113 | 2015 |
| PD1 blockade with low-dose nivolumab in NK/T cell lymphoma failing L-asparaginase: efficacy and safety TSY Chan, J Li, F Loong, PL Khong, E Tse, YL Kwong Annals of hematology 97 (1), 193-196, 2018 | 107 | 2018 |
